[go: up one dir, main page]

MA27864A1 - Composition pharmaceutique pour l'administration par voie nasale de piribedil - Google Patents

Composition pharmaceutique pour l'administration par voie nasale de piribedil

Info

Publication number
MA27864A1
MA27864A1 MA28688A MA28688A MA27864A1 MA 27864 A1 MA27864 A1 MA 27864A1 MA 28688 A MA28688 A MA 28688A MA 28688 A MA28688 A MA 28688A MA 27864 A1 MA27864 A1 MA 27864A1
Authority
MA
Morocco
Prior art keywords
piribedil
pharmaceutical composition
administration
nasrial
solution
Prior art date
Application number
MA28688A
Other languages
English (en)
Inventor
Patrick Wuthrich
Herve Rolland
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of MA27864A1 publication Critical patent/MA27864A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

COMPOSITION PHARMACEUTIQUE POUR L'ADMINISTRATION PAR VOIE NASALE DE PIRIBEDIL La présente invention concerne une composition pharmaceutique pour l'administration par voie nasale de Piribédil en solution ou sous forme de poudre.
MA28688A 2003-07-17 2005-12-27 Composition pharmaceutique pour l'administration par voie nasale de piribedil MA27864A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0308712A FR2857594B1 (fr) 2003-07-17 2003-07-17 Composition pharmaceutique pour l'administration par voie nasale de piribedil

Publications (1)

Publication Number Publication Date
MA27864A1 true MA27864A1 (fr) 2006-04-03

Family

ID=33548200

Family Applications (1)

Application Number Title Priority Date Filing Date
MA28688A MA27864A1 (fr) 2003-07-17 2005-12-27 Composition pharmaceutique pour l'administration par voie nasale de piribedil

Country Status (29)

Country Link
US (1) US20060204449A1 (fr)
EP (1) EP1653963B1 (fr)
JP (1) JP2007516947A (fr)
KR (1) KR100807480B1 (fr)
CN (1) CN100540004C (fr)
AR (1) AR046808A1 (fr)
AT (1) ATE349213T1 (fr)
AU (1) AU2004258714A1 (fr)
BR (1) BRPI0412681A (fr)
CA (1) CA2532631C (fr)
CY (1) CY1106013T1 (fr)
DE (1) DE602004003955T2 (fr)
DK (1) DK1653963T3 (fr)
EA (1) EA011041B1 (fr)
ES (1) ES2279435T3 (fr)
FR (1) FR2857594B1 (fr)
GE (1) GEP20074259B (fr)
HR (1) HRP20070081T5 (fr)
MA (1) MA27864A1 (fr)
MX (1) MXPA06000641A (fr)
MY (1) MY137747A (fr)
NO (1) NO332776B1 (fr)
NZ (1) NZ544460A (fr)
PL (1) PL1653963T3 (fr)
PT (1) PT1653963E (fr)
SI (1) SI1653963T1 (fr)
UA (1) UA85193C2 (fr)
WO (1) WO2005009442A1 (fr)
ZA (1) ZA200600240B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO2303330T3 (fr) * 2008-06-06 2018-04-14
CN105163729A (zh) * 2013-03-13 2015-12-16 N到B有限公司 用于治疗与帕金森氏病相关的运动和抑郁症状的方法、组合物和装置
IT201800005117A1 (it) 2018-05-07 2019-11-07 Acqua irradiata con energie elettromagnetiche per uso terapeutico

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1007402A5 (nl) * 1993-03-26 1995-06-06 Adir Nasale farmaceutische preparaten met progestagene stof.
ATE241984T1 (de) * 1993-03-26 2003-06-15 Franciscus Wilhelmus He Merkus Pharmazeutische zusammensetzungen zur intranasalen verabreichung von apomorphin
FR2710268B1 (fr) * 1993-09-22 1995-10-20 Adir Utilisation de beta-cyclodextrines partiellement méthylées comme promoteurs d'absorption dans la préparation de compositions pharmaceutiques pour l'administration transcutanée de principes actifs.
FR2710265B1 (fr) * 1993-09-22 1995-10-20 Adir Composition pharmaceutique bioadhésive pour la libération contrôlée de principes actifs.
FR2742989B1 (fr) * 1995-12-29 1998-01-23 Adir Composition pharmaceutique bioadhesive pour la liberation controlee de principes actifs
JP2001518923A (ja) * 1997-03-26 2001-10-16 ダブリュ エイチ エム マーカス，フランシスカス 鼻腔用メラトニン組成物
EP0900567A3 (fr) * 1997-09-05 2001-05-02 Pfizer Products Inc. Quinazoline-4-ones antagonistes d'AMPA pour le traitement des dyscinésies associées à la thérapie aux agonistes de la dopamine
US20020002175A1 (en) * 2000-09-19 2002-01-03 Charanjit Behl Nasal delivery of apomorphine in combination with glycol derivatives
US20040028613A1 (en) * 2001-06-25 2004-02-12 Nastech Pharmaceutical Company Inc Dopamine agonist formulations for enhanced central nervous system delivery
FR2827516B1 (fr) * 2001-07-19 2003-09-19 Servier Lab Composition pharmaceutique pour l'administration par voie nasale d'estradiol et de norethisterone

Also Published As

Publication number Publication date
BRPI0412681A (pt) 2006-10-03
DK1653963T3 (da) 2007-04-10
US20060204449A1 (en) 2006-09-14
NO20060743L (no) 2006-02-16
EA200600172A1 (ru) 2006-06-30
PL1653963T3 (pl) 2007-02-28
KR20060031689A (ko) 2006-04-12
SI1653963T1 (sl) 2007-04-30
WO2005009442A1 (fr) 2005-02-03
DE602004003955D1 (de) 2007-02-08
ES2279435T3 (es) 2007-08-16
EP1653963B1 (fr) 2006-12-27
FR2857594B1 (fr) 2005-09-16
HRP20070081T3 (hr) 2007-04-30
NO332776B1 (no) 2013-01-14
EA011041B1 (ru) 2008-12-30
JP2007516947A (ja) 2007-06-28
FR2857594A1 (fr) 2005-01-21
HRP20070081T5 (hr) 2007-08-31
AR046808A1 (es) 2005-12-28
CN100540004C (zh) 2009-09-16
CY1106013T1 (el) 2011-04-06
ZA200600240B (en) 2007-03-28
KR100807480B1 (ko) 2008-02-25
CA2532631A1 (fr) 2005-02-03
EP1653963A1 (fr) 2006-05-10
MXPA06000641A (es) 2006-03-30
MY137747A (en) 2009-03-31
AU2004258714A1 (en) 2005-02-03
CA2532631C (fr) 2011-01-04
NZ544460A (en) 2008-04-30
PT1653963E (pt) 2007-02-28
UA85193C2 (ru) 2009-01-12
ATE349213T1 (de) 2007-01-15
GEP20074259B (en) 2007-12-10
DE602004003955T2 (de) 2007-12-06
CN1819828A (zh) 2006-08-16
HK1094153A1 (zh) 2007-03-23

Similar Documents

Publication Publication Date Title
BR9810658A (pt) Composições farmacêuticas contendo hemissulfato de eletriptano e cafeìna.
TNSN00092A1 (fr) Composes nouveaux antagonistes de npy, procede pour leur preparation et compositions pharmaceutiques les contenant
TR200101499T1 (tr) Azepinoindol türevleri, hazırlanmaları ve kullanımları.
ATE461196T1 (de) Benzodiazepin-cgrp-rezeptor-antagonisten
EP1646276A4 (fr) Nebuliseur pour la production d'un medicament aerosol
MA27153A1 (fr) Formulations pharmaceutiques de derives de platine
EA200600877A1 (ru) Наночастицы для доставки лекарств
MXPA05010859A (es) Antagonistas mchr1 heterociclicos.
DE60334773D1 (de) Formulierungen zur oralen verabreichung von wirkstoffen
ZA200709474B (en) Pharmaceutical formulation of apomorphine for buccal administration
TW200738658A (en) Novel compounds
MY135916A (en) Use of certain affinity nmda antagonists as antidepressants
EP1602366A4 (fr) Timbre transdermique pour l'administration de medicaments ioniques
BE1014502A5 (fr) Compositions pharmaceutiques.
MA27864A1 (fr) Composition pharmaceutique pour l'administration par voie nasale de piribedil
AU2003210850A8 (en) N-substituted3-hydroxy-4-pyridinones and pharmaceuticals containing thereof
MA30691B1 (fr) Compositions pharmaceutiques contenant un anticorps monoclonal anti-idiotypique anti-ca-125 et de l'aluminium.
BR0011845A (pt) Complexo farmacêutico
MXPA04003297A (es) Derivados novedosos de benzotiacina su preparacion y uso.
TNSN00105A1 (fr) Derives de 1-trifluoromethyl-4-hydroxy-7-piperidinyl- aminomethylchromane, procede pour leur preparation et compositions pharmaceutiques les contenant
EP1565162A4 (fr) Composition sous forme de microemulsion pour l'administration orale de biphenyldimethyldicarboxylate
SE9902938D0 (sv) Pharmaceutical compositions
TNSN00211A1 (fr) Derives d'hygromycine a nouveaux, compositions les contenant et leur utilisation
EP1730174A4 (fr) Support peptidique pour l'administration de medicaments
ES2165727T3 (es) Composiciones de administracion por via oral con baja dosificacion de proteinas citotoxicas.